Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Bristol/Myers Squibb Co
Recent news which mentions Bristol/Myers Squibb Co
< Previous
1
2
Next >
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
July 23, 2024
Tags
Novo Nordisk A/S
Merck & Co Inc
Biotech and Pharmaceuticals
From
CNBC.com News
5 things to know before the stock market opens Monday
July 22, 2024
Tags
Government and politics
5 Things to Know
Delta Air Lines Inc
From
CNBC.com News
Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline
June 28, 2024
Tags
Business
Pharmaceuticals
Layoffs
From
CNBC.com News
Cramer's Lightning Round: 'I would not abandon' Cava
June 24, 2024
Tags
stocks
Stock markets
Investment Strategy
From
CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
June 07, 2024
Tags
Healthy Returns
Science
Moderna Inc
From
CNBC.com News
Cramer's Lightning Round: Apple is a buy
May 28, 2024
Tags
S&P 500
T Rowe Price Group Inc
Mad Money
From
CNBC.com News
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A
May 23, 2024
Tags
Health & Science
Fusion Pharmaceuticals Inc
AstraZeneca PLC
From
CNBC.com News
Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug price negotiations
April 29, 2024
Tags
Johnson & Johnson
Health care industry
Bristol/Myers Squibb Co
From
CNBC.com News
Bristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly loss
April 25, 2024
Tags
Biotechnology
Companies
US: News
From
CNBC.com News
5 things to know before the stock market opens Monday
April 22, 2024
Tags
Investment strategy
Politics
Alphabet Inc
From
CNBC.com News
Healthy Returns: J&J cell therapy gains new edge over Bristol Myers rival
April 09, 2024
Tags
Bristol/Myers Squibb Co
Health & Science
Biotech and Pharmaceuticals
From
CNBC.com News
Judge rejects AstraZeneca’s challenge to Medicare drug price negotiations
March 01, 2024
Tags
Bristol/Myers Squibb Co
Biotech and Pharmaceuticals
Health care industry
From
CNBC.com News
Federal judge tosses lobbying group's lawsuit challenging Medicare drug price negotiations
February 13, 2024
Tags
Social issues
Biotechnology
Breaking News: Politics
From
CNBC.com News
Senators to question Merck, J&J and Bristol Myers Squibb CEOs over high U.S. drug pricing
February 08, 2024
Tags
Congress
Health care industry
Johnson & Johnson
From
CNBC.com News
Fourth-quarter earnings are shaping up to be the best of 2023, but there's a catch
February 02, 2024
Tags
Health care industry
Earnings
Technology
From
CNBC.com News
Bristol Myers Squibb results top estimates as new drugs post strong sales growth
February 02, 2024
Tags
Bristol/Myers Squibb Co
Biotech and Pharmaceuticals
Pfizer Inc
From
CNBC.com News
Healthy Returns: J&J, Merck and Bristol Myers Squibb are in the hot seat
January 30, 2024
Tags
Health & Science
Bristol/Myers Squibb Co
Merck & Co Inc
From
CNBC.com News
5 things to know before the stock market opens Monday
January 29, 2024
Tags
Politics
Investment strategy
Novo Nordisk A/S
From
CNBC.com News
Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
January 28, 2024
Tags
Amgen Inc
Biotech and Pharmaceuticals
Merck & Co Inc
From
CNBC.com News
Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
January 26, 2024
Tags
Biotechnology
Moderna Inc
US: News
From
CNBC.com News
Bristol-Myers CEO talks new acquisitions: 'We are writing the next chapter of this company'
January 08, 2024
Tags
Pharmaceuticals
Business
Investment Strategy
From
CNBC.com News
Cramer cheers Monday's tech gains, but tells investors to keep a diverse portfolio with an eye towards health care
January 08, 2024
Tags
Investment Strategy
Business
Stock markets
From
CNBC.com News
Cramer names biopharma companies to watch as industry mergers start to pile up
January 05, 2024
Tags
Pfizer Inc
Bristol/Myers Squibb Co
Seagen Inc
From
CNBC.com News
Cramer's week ahead: Earnings season kicks off after JPMorgan Healthcare Conference
January 05, 2024
Tags
Bristol/Myers Squibb Co
Pfizer Inc
Walgreens Boots Alliance Inc
From
CNBC.com News
Biden administration's Medicare drug price negotiations will face major tests in 2024
December 28, 2023
Tags
Health & Science
Business News
Breaking News: Politics
From
CNBC.com News
Karuna Therapeutics surges 47% after Bristol Myers Squibb announces $14 billion deal
December 22, 2023
Tags
Bristol/Myers Squibb Co
Health & Science
Biotech and Pharmaceuticals
From
CNBC.com News
Jim Cramer explains how FTC chair Lina Khan is hurting investor portfolios
December 18, 2023
Tags
Bristol/Myers Squibb Co
Merck & Co Inc
Walgreens Boots Alliance Inc
From
CNBC.com News
Pfizer shares fall as 2024 revenue and profit forecast disappoints
December 13, 2023
Tags
Health & Science
Business News
US: News
From
CNBC.com News
Jim Cramer explains why it's hard to be bullish on the healthcare sector
November 30, 2023
Tags
Investing
Business News
Humana Inc
From
CNBC.com News
Here are 16 stocks Jim Cramer is watching, including Microsoft, Chevron, Southwest
October 30, 2023
Tags
CNBC Investing Club: Analysis
Sanofi SA
CNBC Investing Club: Newsletter
From
CNBC.com News
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.